Prevention and treatment of influenza A and B.
Imustat is an antiviral agent that specifically inhibits influenza A and B viruses, including the highly pathogenic subtypes A (H1N1) pdm09 and A (H5N1).
According to the mechanism of antiviral action, it belongs to inhibitors of fusion (fusion), interacts with the hemagglutinin of the virus and prevents the fusion of the lipid envelope of the virus and cell membranes.
Therapeutic efficacy in influenza is manifested in a decrease in the duration and severity of the course of the disease and its main symptoms, as well as in a decrease in the incidence of complications associated with influenza.
The product does not have a negative effect on the human body when used in recommended doses.